These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Androgens and bone metabolism. Significance in osteoporosis in man and woman]. Kasperk CH; Ziegler R Dtsch Med Wochenschr; 1992 Jun; 117(25):990-6. PubMed ID: 1611969 [No Abstract] [Full Text] [Related]
6. [Age-dependent decrease in plasma androgens, and role of androgens in bone mineral density and bone metabolism]. Adachi M; Takayanagi R Clin Calcium; 2006 Mar; 16(3):419-27. PubMed ID: 16508123 [TBL] [Abstract][Full Text] [Related]
7. Restoration of bone mass in male hypogonadal osteopenic subjects by androgens. Gupta SK; Ghotekar LH Natl Med J India; 1997; 10(6):285-7. PubMed ID: 9481102 [No Abstract] [Full Text] [Related]
8. Osteoporosis: the clinical problem. Fogelman I Scott Med J; 1986 Jul; 31(3):199-201. PubMed ID: 3798087 [No Abstract] [Full Text] [Related]
9. [Hormone replacement Up-to-date. The effect of androgen replacement therapy on bone metabolism]. Miyagawa Y; Tsujimura A; Matsuoka Y; Okuyama A Clin Calcium; 2007 Sep; 17(9):1372-7. PubMed ID: 17767026 [TBL] [Abstract][Full Text] [Related]
10. [Role of androgens and DHEA in bone metabolism]. Adachi M; Takayanagi R Clin Calcium; 2006 Jan; 16(1):61-6. PubMed ID: 16397352 [TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of osteoporosis in male hypogonadism]. Tsukamoto T; Itoh N Clin Calcium; 2006 Mar; 16(3):481-5. PubMed ID: 16508132 [TBL] [Abstract][Full Text] [Related]
13. [The effect of hormones and endocrine diseases on bone tissue in adults]. Holló I Orv Hetil; 1988 Jun; 129(26):1351-5. PubMed ID: 3292988 [No Abstract] [Full Text] [Related]
14. [Risk fractures of fracture and osteoporosis]. Mellström D Lakartidningen; 2006 Oct 4-10; 103(40):2983-5. PubMed ID: 17115664 [No Abstract] [Full Text] [Related]
15. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis]. Fukunaga M Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266 [TBL] [Abstract][Full Text] [Related]
17. [Osteoporosis and male hypogonadism]. Medraś M; Jóźków P Pol Merkur Lekarski; 2000 Jul; 8(49):494-7. PubMed ID: 11070725 [TBL] [Abstract][Full Text] [Related]
18. [Drugs with side effects affecting calcium homeostasis, bone metabolism and risk of fractures]. Nielsen LR; Vestergaard P; Mosekilde L Ugeskr Laeger; 2005 Feb; 167(9):1026-30. PubMed ID: 15803998 [No Abstract] [Full Text] [Related]
19. [Fracture risk and biochemical markers of bone turnover]. Chaki O Clin Calcium; 2005 Aug; 15(8):1339-45. PubMed ID: 16062004 [TBL] [Abstract][Full Text] [Related]
20. [New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?]. Yamaguchi T; Sugimoto T Clin Calcium; 2009 Jan; 19(1):38-43. PubMed ID: 19122263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]